Putnam Investments’s NEVRO CORP. NVRO Stock Holding History

Putnam Investments’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$364K	Sell	16,898 -1,604	-9%	-$28.6K	﹤0.01%	1052
2023 Q3	$356K	Buy	18,502 +4,981	+37%	+$106K	﹤0.01%	1013
2023 Q2	$344K	Buy	+13,521	New	+$390K	﹤0.01%	1055
2021 Q4	–	Sell	-46,680	Closed	-$5.43M	–	1214
2021 Q3	$5.43M	Buy	46,680 +173	+0.4%	+$22.6K	0.01%	494
2021 Q2	$7.71M	Buy	46,507 +11,585	+33%	+$1.81M	0.01%	426
2021 Q1	$4.87M	Sell	34,922 -34,086	-49%	-$5.56M	0.01%	500
2020 Q4	$11.9M	Buy	69,008 +15,586	+29%	+$2.52M	0.02%	344
2020 Q3	$7.44M	Buy	53,422 +36,162	+210%	+$4.83M	0.01%	393
2020 Q2	$2.06M	Buy	+17,260	New	+$2.05M	﹤0.01%	669

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Putnam Investments's NVRO Position: Q4 2023 in Review

Putnam Investments reduced its NEVRO CORP. (NVRO) stake by 8.7% in Q4 2023, selling an estimated $28.6K and leaving 16,898 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Putnam Investments first reported a position in NVRO in Q2 2020 and has held it in 9 quarters since. The position peaked at $11.9M in Q4 2020. 140 funds tracked by Wall St. Rank hold NVRO as of Q4 2023.

Putnam Investments held 16,898 shares of NEVRO CORP. worth $364K as of Q4 2023.
Putnam Investments sold 1,604 NEVRO CORP. shares in Q4 2023, an estimated $28.6K.
NEVRO CORP. made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1052 holding.
Putnam Investments first reported a position in NEVRO CORP. in Q2 2020 and has held it in 9 quarters since.
Putnam Investments's NEVRO CORP. position peaked at $11.9M in Q4 2020.
140 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.